| Basics |
Co-Diagnostics, Inc.
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
|
| IPO Date: |
July 12, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$11.93M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 4.19%
|
| Avg Daily Range (30 D): |
$0.01 | 4.20%
|
| Avg Daily Range (90 D): |
$0.02 | 5.15%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.07M |
| Avg Daily Volume (30 D): |
2.64M |
| Avg Daily Volume (90 D): |
1.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
213 |
| Avg Trade Size (Sh.) (30 D): |
647 |
| Avg Trade Size (Sh.) (90 D): |
631 |
| Institutional Trades |
| Total Inst.Trades: |
365 |
| Avg Inst. Trade: |
$1.31M |
| Avg Inst. Trade (30 D): |
$.7M |
| Avg Inst. Trade (90 D): |
$.7M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.97M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
140.4K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.15
|
$-.23
|
$-.24
|
|
Diluted EPS
|
$-1.15
|
$-.23
|
$-.24
|
|
Revenue
|
$ 1M
|
$ .16M
|
$ .05M
|
|
Gross Profit
|
$ .4M
|
$ .13M
|
$ .03M
|
|
Net Income / Loss
|
$ -35.99M
|
$ -7.73M
|
$ -7.53M
|
|
Operating Income / Loss
|
$ -38.75M
|
$ -8.06M
|
$ -8.55M
|
|
Cost of Revenue
|
$ .61M
|
$ .03M
|
$ .02M
|
|
Net Cash Flow
|
$ -11.98M
|
$ M
|
$ M
|
|
PE Ratio
|
|
|
|
|
|
|
